LTFU for all cell and gene therapy studies

Trial Identifier: D9341C00001
Sponsor: AstraZeneca
NCTID:: NCT06194461
Start Date: June 2024
Primary Completion Date: November 2041
Study Completion Date: November 2041
Condition: Liver Cancer; Prostate Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, AZ Phoenix, AZ, US, 85054
US, CA Duarte, CA, US, 91010
US, CA Orange, CA, US, 92868
US, CA San Francisco, CA, US, 94143
US, FL Jacksonville, FL, US, 32224
US, FL Tampa, FL, US, 33612
US, GA Atlanta, GA, US, 30322
US, KS Westwood, KS, US, 66205
US, MN Rochester, MN, US, 55905
US, NJ Hackensack, NJ, US, 07601
US, NY New York, NY, US, 10065
US, OH Columbus, OH, US, 43210
US, OR Portland, OR, US, 97239
US, PA Philadelphia, PA, US, 19104
US, PA Pittsburgh, PA, US, 15237
US, TX Houston, TX, US, 77030